InSightec Offers Non-Invasive Uterine Fibroid Treatment in Shanghai

InSightec Ltd., an Israeli medical device maker, opened three Shanghai centers that offer its ExAblate therapy as a non-invasive treatment for uterine fibroids. ExAblate is a MR guided Focused Ultrasound machine that destroys the fibroids without surgery. InSightec is majority owned by GE Healthcare (NYSE: GE). The three centers are located in Shanghai First People's Hospital, Huashan Hospital and Fudan Cancer Center. The CFDA approved ExAblate last year. More details.... Share this with colleagues: // //